Emerade epinephrine auto-injectors recall in Canada: device failure
In plain language
This recall involves all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg strengths) sold in Canada. They are being recalled because they may fail to activate or activate too early if dropped. Stop using the product and follow the return steps in the official notice.
What to do
- Return your Emerade auto-injector to your pharmacy for a replacement as soon as possible.
- Do not dispose of your Emerade auto-injector until you have a replacement.
- If a life-threatening allergic reaction occurs before you get a replacement, use your Emerade device and seek emergency medical attention.
- Consult your pharmacist to understand how to use the replacement auto-injector.
- Contact Bausch Health, Canada Inc. at 1-800-361-4261 or canada.customerservice@bauschhealth.com for questions.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Emerade epinephrine auto-injectors 0.3 mg
Lot: Y0225B2A, Z0076B1A, Z0034B2C, Z0198B3A, Z0198B3B
Date codes: 2023-05-31, 2023-06-30, 2023-08-30, 2024-10-31
Emerade epinephrine auto-injectors 0.5 mg
Lot: Y0225C1A, Z0034C1A, Z0076C2A, Z0088C3A, Z0153C2A, Z0236C1C, Z0088C3B, Z0128C1B, Z0153C2B
Date codes: 2023-05-31, 2023-06-30, 2023-08-30, 2023-08-31, 2024-05-31, 2024-08-31, 2024-11-30
Why this matters
Device failure leading to inadequate treatment
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the date code
Date codes are usually printed near the best-before date or on the packaging seam.
Affected date codes: 2023-05-31, 2023-06-30, 2023-08-30, 2023-08-31, 2024-05-31, 2024-08-31, 2024-10-31, 2024-11-30
- 3
Check the lot number
Lot numbers identify specific production batches.
Affected lots: Y0225B2A, Z0076B1A, Z0034B2C, Z0198B3A, Z0198B3B, Y0225C1A, Z0034C1A, Z0076C2A, Z0088C3A, Z0153C2A, Z0236C1C, Z0088C3B, Z0128C1B, Z0153C2B
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Device failure leading to inadequate treatment
What should consumers do?
Return your Emerade auto-injector to your pharmacy for a replacement as soon as possible. Do not dispose of your Emerade auto-injector until you have a replacement. If a life-threatening allergic reaction occurs before you get a replacement, use your Emerade device and seek emergency medical attention. Consult your pharmacist to understand how to use the replacement auto-injector. Contact Bausch Health, Canada Inc. at 1-800-361-4261 or canada.customerservice@bauschhealth.com for questions.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Device failure leading to inadequate treatment
When was this product recalled?
This product was recalled on May 5, 2023.
Is the Emerade brand affected by this recall?
Yes, Emerade products are affected by this recall. This recall involves all lots of Emerade epinephrine auto-injectors (0.3 mg and 0.5 mg strengths) sold in Canada. They are being recalled because they may fail to activate or activate too early if dropped. Stop using the product and follow the return steps in the official notice.